- Home
- /
- Treatment
- /
- Page 140
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Dianeal peritoneal dialysis solution with 1.1% amino acids | For use as a nutritional supplement for the treatment of malnourishment in patients undergoing continuous ambulatory peritoneal dialysis | Baxter Healthcare Corporation;1620 Waukegan Road;McGaw Park, Illinois, 60085 | June 11, 1992 | |
Imported fire ant venom, allergenic extract | For skin testing of victims of fire ant stings to confirm fire ant sensitivity and if positive, for use as immunotherapy for the prevention of IgE-mediated anaphylactic reactions | ALK Laboratories, Inc.;Research Center, 27 Village Lane;Wallingford, Connecticut, 06492 | May 12, 1992 | |
5,6-dihydro-5-azacytidine | Malignant mesothelioma | ILEX Oncology, Inc.;4545 Horizon Hill Blvd.;San Antonio, Texas, 78229 | May 11, 1992 | |
Ciliary neurotrophic factor, recombinant human | Motor neuron disease | Syntex-Synergen Neuroscience;3200 Walnut Street;Boulder, Colorado, 80301 | May 8, 1992 | |
Sodium Monomercaptoundecahydro-closo-dodecaborate | Glioblastoma | Neutron Technology Corp.& Neutron R&D; Partner;877 Main Street, Suite 402;Boise, Idaho, 83702 | April 15, 1992 | |
Alitretinoin | Acute promyelocytic leukemia | Ligand Pharmaceuticals, Inc.;10275 Science Center Dr.;San Diego, California, 92121 | April 10, 1992 | |
Anaritide acetate | Improvement of early renal allograft function following renal transplantation | Scios, Inc.;2450 Bayshore Parkway;Mountain View, California, 94043 | April 10, 1992 | |
Technetium Tc99m murine monoclonal antibody (IgG2a) to B cell | Acute lymphoblastic leukemia | Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950 | April 7, 1992 | |
Arginine butyrate | Beta-hemoglobinopathies and beta-thalassemia | Perrine, Susan P., M.D.;Boston University, Cancer Research Center;Boston, Massachusetts, 02118 | April 7, 1992 | |
Ciliary neurotrophic factor, recombinant human | Spinal muscular atrophies | Syntex-Synergen Neuroscience;3200 Walnut Street;Boulder, Colorado, 80301 | April 2, 1992 | |
Polymeric oxygen | Sickle cell anemia | Capmed USA;P.O. Box 14;Bryn Mawr, Pennsylvania, 19010 | March 25, 1992 | |
Human immunodeficiency virus immune globulin | HIV-infected pregnant women and infants of HIV-infected mothers | NABI;5800 Park of Commerce Blvd., NW;Boca Raton, Florida, 33487 | March 25, 1992 | |
Butyrylcholinesterase | For the reduction and clearance of toxic blood levels of cocaine encountered during a drug overdose | Shire Laboratories Inc.;1550 East Gude Drive;Rockville, Maryland, 20850 | March 25, 1992 | |
HIV neutralizing antibodies | Acquired immunodeficiency syndrome | Hemacare Corporation;4954 Van Nuys Boulevard;Sherman Oaks, California, 91403 | March 24, 1992 | |
Melphalan | Metastatic Melanoma | Glaxo Wellcome Research and Development;5 Moore Drive, PO Box 13398;Research Triangle Park, North Carolina, 27709 | March 3, 1992 | |
Pilocarpine HCl | Sjogren’s syndrome | MGI Pharma, Inc.;5775 West Old Shakopee Rd., Suite 100;Bloomington, Minnesota, 55437 | February 28, 1992 | |
Diazepam viscous solution for rectal administration | For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity | Valeant Pharmaceuticals;3300 Hyland Avenue;Costa Mesa, California, 92626 | February 25, 1992 | |
Thyrotropin alpha | As an adjunct in the diagnosis of thyroid cancer | Genzyme Corporation;One Kendall Square;Cambridge, Massachusetts, 02139 | February 24, 1992 | |
Melphalan | Multiple myeloma | Glaxo Wellcome Inc.;5 Moore Drive;Research Triangle Park, North Carolina, 27709 | February 24, 1992 | |
Loxoribine | Common variable immunodeficiency | R. W. Johnson Pharmaceutical Research Institute;Route 202, P.O. Box 300;Raritan, New Jersey, 08869 | February 24, 1992 | |
Aminosalicylic acid | Tuberculosis infections | Jacobus Pharmaceutical Company;37 Cleveland Avenue, P.O. Box 5290;Princeton, New Jersey, 08540 | February 19, 1992 | |
Papaverine topical gel | Sexual dysfunction in spinal cord injury patients | Pharmedic Company;417 Harvester Court;Wheeling, Illinois, 60090 | February 6, 1992 | |
L-baclofen | Intractable spasticity in children with cerebral palsy | Osmotica Pharmaceutical Corp.;1205 Culbreth Drive, Suite 200;Wilmington, North Carolina, 28405 | January 30, 1992 | |
Ciliary neurotrophic factor | Amyotrophic lateral sclerosis | Regeneron Pharmaceuticals Inc;777 Old Saw Mill River Road;Tarrytown, New York, 10591 | January 30, 1992 | |
Ananain, comosain | For the enzymatic debridement of severe burns | Genzyme Corporation;One Kendall Square;Cambridge, Massachusetts, 02139 | January 21, 1992 |